Zepbound 7.5 MG/0.5 ML pen 0.5ML
Ended Awarded Last action
- Contract number
- SPE2DR26FMK6Z
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $11,677
Award facts
- Contract value 100% obligated
- $11,676.73 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a $11,676.73 delivery order to AmerisourceBergen Drug Corp for Zepbound (semaglutide) 7.5 mg/0.5 mL pens on January 22, 2026, with completion scheduled for January 23, 2026. This is a firm fixed-price order with no set-aside designation, competitively awarded under open competition. The pharmaceutical product will be delivered to the contractor's facility in Conshohocken, Pennsylvania. This delivery order is a child contract issued under AmerisourceBergen's parent company Cencora, Inc.'s larger Indefinite Delivery Contract with DLA Troop Support Medical, valued at up to $999.99 million through December 2026, which serves as the primary vehicle for supplying pharmaceutical products and medical supplies to military healthcare programs worldwide.
AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, regularly fulfills federal medical procurement needs through its extensive portfolio of brand-name and generic medications, vaccines, and specialized medical supplies across multiple therapeutic domains. The company's federal contracts with DLA consistently involve firm fixed-price delivery orders covering products ranging from high-value specialty medications to routine pharmaceuticals, demonstrating its capability to support military treatment facilities, veterans' healthcare programs, and other federal medical institutions. Zepbound, a diabetes and weight management medication, aligns with the company's established track record of supplying diabetes-related pharmaceutical products to federal health systems.
Quick answers
Who was awarded contract SPE2DR26FMK6Z?
SPE2DR26FMK6Z was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on January 22, 2026.
How much is contract SPE2DR26FMK6Z worth?
The government has obligated $11,677 on SPE2DR26FMK6Z.
Is contract SPE2DR26FMK6Z an order under another contract?
Yes. SPE2DR26FMK6Z is a delivery order under SPE2DR25D1200, an indefinite delivery contract.
Was contract SPE2DR26FMK6Z competed?
The extent of competition for SPE2DR26FMK6Z was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award